Preview this article 1 min The U.S. Department of the Treasury has designated BNY as a financial agent to help implement a ...
Wugen, Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf cell therapies for the treatment of hematological malignancies, today announced that the U.S. Food and Drug ...
(“AV”) (NASDAQ: AVAV), a global leader in autonomous systems and intelligence services, today announced its selection by the ...
remove-circle Internet Archive's in-browser bookreader "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on. Please see ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results